Ameriprise’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$198M Buy
1,867,399
+191,637
+11% +$20.3M 0.05% 364
2025
Q1
$208M Sell
1,675,762
-151,896
-8% -$18.9M 0.06% 326
2024
Q4
$225M Buy
1,827,658
+315,608
+21% +$38.9M 0.06% 311
2024
Q3
$168M Buy
1,512,050
+50,727
+3% +$5.65M 0.04% 382
2024
Q2
$156M Buy
1,461,323
+92,374
+7% +$9.86M 0.04% 387
2024
Q1
$165M Buy
1,368,949
+56,178
+4% +$6.76M 0.05% 385
2023
Q4
$161M Buy
1,312,771
+13,159
+1% +$1.62M 0.05% 372
2023
Q3
$168M Buy
1,299,612
+57,717
+5% +$7.47M 0.06% 341
2023
Q2
$154M Buy
1,241,895
+69,018
+6% +$8.56M 0.05% 367
2023
Q1
$172M Buy
1,172,877
+36,839
+3% +$5.39M 0.06% 335
2022
Q4
$181M Buy
1,136,038
+129,662
+13% +$20.7M 0.06% 315
2022
Q3
$134M Buy
1,006,376
+159,511
+19% +$21.3M 0.05% 381
2022
Q2
$132M Buy
846,865
+377,948
+81% +$58.9M 0.05% 388
2022
Q1
$72.5M Buy
468,917
+67,696
+17% +$10.5M 0.02% 649
2021
Q4
$50.6M Buy
401,221
+281,523
+235% +$35.5M 0.01% 836
2021
Q3
$15.6M Sell
119,698
-38,109
-24% -$4.96M 0.01% 1476
2021
Q2
$28M Buy
157,807
+4,959
+3% +$881K 0.01% 1111
2021
Q1
$25.2M Sell
152,848
-78,255
-34% -$12.9M 0.01% 1153
2020
Q4
$38.1M Buy
231,103
+4,306
+2% +$711K 0.01% 874
2020
Q3
$32.3M Buy
226,797
+100,493
+80% +$14.3M 0.01% 823
2020
Q2
$13.9M Sell
126,304
-8,769
-6% -$968K 0.01% 1295
2020
Q1
$13.5M Buy
135,073
+1,483
+1% +$148K 0.01% 1183
2019
Q4
$20M Buy
133,590
+9,894
+8% +$1.48M 0.01% 1204
2019
Q3
$15.8M Buy
123,696
+12,101
+11% +$1.55M 0.01% 1323
2019
Q2
$15.9M Buy
111,595
+5,954
+6% +$850K 0.01% 1335
2019
Q1
$15.1M Sell
105,641
-240,612
-69% -$34.4M 0.01% 1340
2018
Q4
$42.9M Buy
346,253
+213,678
+161% +$26.5M 0.02% 677
2018
Q3
$22.3M Sell
132,575
-1,686
-1% -$284K 0.01% 1218
2018
Q2
$23.1M Sell
134,261
-40,099
-23% -$6.91M 0.01% 1073
2018
Q1
$26.3M Sell
174,360
-5,540
-3% -$837K 0.01% 974
2017
Q4
$24.2M Sell
179,900
-61,646
-26% -$8.3M 0.01% 956
2017
Q3
$35.3M Buy
241,546
+61,338
+34% +$8.97M 0.02% 694
2017
Q2
$28M Sell
180,208
-1,196
-0.7% -$186K 0.01% 805
2017
Q1
$26.3M Sell
181,404
-78,888
-30% -$11.4M 0.01% 841
2016
Q4
$28.4M Buy
260,292
+68,671
+36% +$7.49M 0.02% 775
2016
Q3
$23.3M Sell
191,621
-9,032
-5% -$1.1M 0.01% 846
2016
Q2
$28.4M Sell
200,653
-15,620
-7% -$2.21M 0.02% 731
2016
Q1
$28.2M Buy
216,273
+26,276
+14% +$3.43M 0.02% 742
2015
Q4
$26.7M Buy
189,997
+61,984
+48% +$8.71M 0.02% 759
2015
Q3
$17.2M Buy
128,013
+726
+0.6% +$97.3K 0.01% 1041
2015
Q2
$22.4M Sell
127,287
-31,641
-20% -$5.57M 0.01% 932
2015
Q1
$27.5M Sell
158,928
-379,760
-70% -$65.6M 0.02% 806
2014
Q4
$88.2M Sell
538,688
-264,375
-33% -$43.3M 0.05% 350
2014
Q3
$129M Sell
803,063
-109,466
-12% -$17.6M 0.08% 267
2014
Q2
$134M Buy
912,529
+38,025
+4% +$5.59M 0.08% 254
2014
Q1
$121M Sell
874,504
-239,482
-21% -$33.2M 0.07% 270
2013
Q4
$141M Buy
1,113,986
+185,340
+20% +$23.5M 0.09% 249
2013
Q3
$85.5M Buy
928,646
+258,816
+39% +$23.8M 0.06% 356
2013
Q2
$46M Buy
+669,830
New +$46M 0.03% 548